Eze Diagnon Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 106.81%
- Profit Growth 102.93%
- Ebitda 86.00%
- Net Worth 17.03%
- Total Assets -26.37%
About Eze Diagnon Healthcare
Eze Diagnon Healthcare Private Limited (EDHPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 June 2017 (Seven years and seven months 28 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gulshan Kumar and Vishwajeet Singh serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TZ2017PTC029024
-
Company No.
029024
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jun 2017
-
Date of AGM
30 Oct 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Eze Diagnon Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishwajeet Singh
|
Additional Director | 12-Oct-2017 | Current |
|
Gulshan Kumar
|
Additional Director | 25-Sep-2017 | Current |
Financial Performance of Eze Diagnon Healthcare.
Eze Diagnon Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 106.81% increase. The company also saw a substantial improvement in profitability, with a 102.93% increase in profit. The company's net worth Soared by an impressive increase of 17.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eze Diagnon Healthcare?
In 2018, Eze Diagnon Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Anuvanshiki (Opc) Private LimitedGulshan Kumar is a mutual person
-
Shree Kumbha Scientific Private Limited
Gulshan Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eze Diagnon Healthcare?
Unlock and access historical data on people associated with Eze Diagnon Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eze Diagnon Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eze Diagnon Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
